Cancer therapeutics
Member count: 11-50
Total raised: $24.6M
Investors 1
| Date | Name | Website |
| 17.07.2021 | ARCH Ventu... | archventur... |
Funding Rounds 2
| Date | Series | Amount | Investors | Deal News |
| 25.03.2013 | Series B | $14M | - | finsmes.co... |
| 09.09.2011 | Series B | $10.6M | - | finsmes.co... |
Mentions in press and media 10
| Date | Title | Description | Category | Author | Source |
| 23.12.2013 | Deals of t... | Venture capital investing in W... | - | John Cook | geekwire.c... |
| 29.03.2013 | Seattle bi... | Its lead antibody, being devel... | - | - | medcitynew... |
| 25.03.2013 | Theraclone... | Theraclone Sciences, a Seattle... | funding U... | - | finsmes.co... |
| 25.03.2013 | Theraclone... | SEATTLE, WA, Therapeutic ant... | - | - | vcnewsdail... |
| 09.09.2011 | Theraclone... | Theraclone Sciences, Inc., a S... | funding U... | - | finsmes.co... |
| 09.09.2011 | Theraclone... | Previous investors ARCH Vent... | - | - | vcnewsdail... |
| 09.09.2011 | Theraclone... | Theraclone Sciences, a Seattle... | - | John Cook | geekwire.c... |
| 08.09.2011 | Amgen ... | Thousand Oaks-based biotech gi... | - | - | socaltech.... |
| 25.03.2010 | FDA Panel ... | Share Share on Facebook Share ... | - | Luke Timme... | xconomy.co... |
| - | Seattle bi... | Seattle-based biotech Theraclo... | - | - | medcitynew... |